Core Insights - China Biotechnology Services (08037) announced significant progress for its flagship project, Pengbo (Hainan) Boron Neutron Hospital, located in the Boao Lecheng International Medical Tourism Pilot Zone, with the NeuCure neutron irradiation system achieving its first beam output on November 20, 2025 [1] - The NeuCure system is the only boron neutron therapy system globally that has received formal medical device registration and can be directly applied in routine clinical treatment, not just in clinical trials [1] - Clinical treatment services are expected to officially commence in the first quarter of 2026, supported by favorable policies from the Boao Lecheng zone [1] Project Milestones - The successful beam output confirms that the core components of the system meet design specifications, marking a transition from equipment installation to beam debugging [1] - This milestone lays a solid foundation for subsequent key tasks, including precise neutron dose rate control, beam physics validation, and biological effect assessment [1] - The project aims to provide safe and precise boron neutron therapy services for cancer patients, ensuring high standards in clinical treatment progression [1]
中国生物科技服务：硼中子治疗装置成功实现首次出束